https://old.international-biopharma.com/moderna-plans-to-triple-coronavirus-vaccine-production-next-year/ 2021-04-30T13:18:08+00:00 https://old.international-biopharma.com/pfizer-buys-infectious-disease-biotech-amplyx/ 2021-04-30T13:17:16+00:00 https://old.international-biopharma.com/biomarin-partners-with-allen-institute-to-develop-gene-therapies-for-the-brain/ 2021-04-30T13:16:15+00:00 https://old.international-biopharma.com/lilly-citing-fda-feedback-wont-seek-speedy-approval-of-alzheimers-drug/ 2021-04-30T13:15:15+00:00 https://old.international-biopharma.com/a-serious-side-effect-puts-a-biotechs-eye-gene-therapy-in-limbo/ 2021-04-30T13:12:45+00:00 https://old.international-biopharma.com/wall-street-fears-amgens-tough-first-quarter-is-just-the-start/ 2021-04-30T13:11:28+00:00 https://old.international-biopharma.com/atmps-and-ori-biotech-collaborate-on-an-integrated-digital-platform-for-cell-and-gene-therapy-developers/ 2021-04-29T09:44:38+00:00 https://old.international-biopharma.com/cphi-post-pandemic-executive-pharma-survey-covid-19-driving-manufacturing-and-cdmos-driving-growth/ 2021-04-26T08:43:36+00:00 https://old.international-biopharma.com/fda-cdc-support-resuming-use-of-jj-vaccine-after-advisory-panel-vote/ 2021-04-26T07:59:12+00:00 https://old.international-biopharma.com/fda-cites-emergent-for-failings-at-plant-that-contaminated-jj-doses/ 2021-04-26T07:58:12+00:00 https://old.international-biopharma.com/bluebird-to-withdraw-gene-therapy-from-germany-after-dispute-over-price/ 2021-04-26T07:57:08+00:00 https://old.international-biopharma.com/with-money-pouring-into-biotech-versant-raises-another-950m/ 2021-04-26T07:54:03+00:00 https://old.international-biopharma.com/lilly-to-seek-first-approval-of-an-autoimmune-drug-for-hair-loss/ 2021-04-26T07:52:59+00:00 https://old.international-biopharma.com/lilly-asks-fda-to-revoke-clearance-of-first-covid-19-antibody-drug/ 2021-04-26T07:51:56+00:00 https://old.international-biopharma.com/thermo-fisher-to-buy-research-contractor-ppd-in-17b-deal/ 2021-04-16T08:52:42+00:00 https://old.international-biopharma.com/cancer-biotech-tango-to-go-public-through-350m-spac-deal/ 2021-04-16T08:51:39+00:00 https://old.international-biopharma.com/sage-biogen-drug-reduces-tremors-but-side-effects-could-limit-potential/ 2021-04-16T08:50:08+00:00 https://old.international-biopharma.com/gsk-stops-studies-testing-closely-watched-cancer-immunotherapy/ 2021-04-16T08:41:45+00:00 https://old.international-biopharma.com/moderna-watches-for-waning-immunity-as-new-data-show-durable-vaccine-protection/ 2021-04-16T08:40:35+00:00 https://old.international-biopharma.com/merck-in-latest-covid-19-setback-scraps-one-drug-and-pins-hopes-on-another/ 2021-04-16T08:39:13+00:00 https://old.international-biopharma.com/lilly-claims-promising-finding-in-failed-study-of-covid-19-drug/ 2021-04-11T20:15:25+00:00 https://old.international-biopharma.com/with-new-data-merck-could-be-first-to-bring-immunotherapy-to-early-kidney-cancer/ 2021-04-11T20:14:04+00:00 https://old.international-biopharma.com/biogen-adds-a-late-stage-prospect-to-its-growing-biosimilar-business/ 2021-04-11T20:12:58+00:00 https://old.international-biopharma.com/gilead-wins-full-approval-for-drug-acquired-in-immunomedics-deal/ 2021-04-11T20:12:05+00:00 https://old.international-biopharma.com/astrazenecas-coronavirus-vaccine-possibly-linked-to-rare-blood-clots-ema-says/ 2021-04-11T20:11:13+00:00 https://old.international-biopharma.com/fibrogen-admits-misleading-safety-data-for-anemia-drug-dimming-prospects/ 2021-04-11T20:10:15+00:00 https://old.international-biopharma.com/metrion-biosciences-closes-2-7m-new-equity-financing/ 2021-04-06T08:47:40+00:00 https://old.international-biopharma.com/uniqure-says-hemophilia-gene-therapy-likely-not-cause-of-study-volunteers-cancer/ 2021-04-01T13:58:46+00:00 https://old.international-biopharma.com/amgen-acquires-a-small-biotech-and-its-inflammatory-disease-research/ 2021-04-01T13:57:30+00:00 https://old.international-biopharma.com/ftc-challenges-illuminas-7b-grail-buyout-amid-new-scrutiny-of-life-science-deals/ 2021-04-01T13:56:30+00:00 https://old.international-biopharma.com/fda-turns-back-keytruda-delaying-immunotherapys-arrival-in-early-cancer/ 2021-04-01T13:50:45+00:00 https://old.international-biopharma.com/pfizer-biontechs-vaccine-protects-12-to-15-year-olds-from-covid-19-in-study/ 2021-04-01T13:49:53+00:00 https://old.international-biopharma.com/fda-advisers-reassert-case-against-approval-of-biogens-alzheimers-drug/ 2021-04-01T13:48:54+00:00 https://old.international-biopharma.com/the-science-is-stacking-up-for-regenerative-medicine/ 2021-03-30T14:11:23+00:00 https://old.international-biopharma.com/biosimilars-increasing-regulatory-focus-on-orthogonal-analytical-characterisation/ 2021-03-30T14:07:36+00:00 https://old.international-biopharma.com/exploiting-epigenetics-to-systematically-optimise-culture-conditions-for-cellular-therapies/ 2021-03-30T14:04:23+00:00 https://old.international-biopharma.com/developments-in-non-invasive-preclinical-lung-imaging-to-support-drug-discovery/ 2021-03-30T14:01:16+00:00 https://old.international-biopharma.com/why-patient-diversity-in-research-must-become-the-norm/ 2021-03-30T13:58:01+00:00 https://old.international-biopharma.com/automated-identification-of-cardiac-hypertrophy-modulators-using-a-hipsc-derived-disease-model/ 2021-03-30T13:54:34+00:00 https://old.international-biopharma.com/live-cell-imaging-non-invasive-kinetic-data-to-better-understand-cell-viability/ 2021-03-30T13:51:14+00:00 https://old.international-biopharma.com/unlocking-the-biomarker-revolution-in-clinical-trials/ 2021-03-30T13:48:25+00:00 https://old.international-biopharma.com/maximising-mabs-purification-efficiency-focus-areas-for-reducing-bottlenecks-in-downstream-processing/ 2021-03-30T13:45:38+00:00 https://old.international-biopharma.com/high-throughput-sequencing-technologies-are-revolutionising-antibody-discovery/ 2021-03-30T13:41:30+00:00 https://old.international-biopharma.com/battling-biohazardous-liquid-laboratory-waste/ 2021-03-30T13:38:11+00:00 https://old.international-biopharma.com/using-electronic-pipetting-and-automated-dispensing-technologies-to-accelerate-sample-preparation-for-rt-pcr-applications/ 2021-03-30T13:26:06+00:00 https://old.international-biopharma.com/transforming-drug-discovery-and-medicine-research/ 2021-03-30T09:23:55+00:00 https://old.international-biopharma.com/astrazeneca-under-fire-tries-to-repair-image-with-new-vaccine-data/ 2021-03-25T15:53:15+00:00 https://old.international-biopharma.com/us-stops-rollout-of-lillys-first-covid-19-antibody-over-variant-concerns/ 2021-03-25T15:51:37+00:00 https://old.international-biopharma.com/drugmakers-flock-to-vinetis-fix-for-a-cell-gene-therapy-problem/ 2021-03-25T15:50:27+00:00 https://old.international-biopharma.com/slaoui-steps-down-from-two-more-biotechs-after-harassment-claim/ 2021-03-25T15:49:30+00:00 https://old.international-biopharma.com/roche-immunotherapy-notches-a-win-in-early-lung-cancer-pressuring-merck/ 2021-03-25T15:48:39+00:00 https://old.international-biopharma.com/regeneron-joins-lilly-in-proving-lower-dose-antibody-drugs-can-thwart-covid-19/ 2021-03-25T15:47:41+00:00 https://old.international-biopharma.com/three-drugmakers-nab-639m-as-biotechs-ipo-pace-eclipses-a-record-year/ 2021-03-21T20:46:07+00:00 https://old.international-biopharma.com/abbvies-approval-delay-raises-further-concerns-about-jak-drugs/ 2021-03-21T20:44:41+00:00 https://old.international-biopharma.com/eu-uk-throw-support-behind-astrazenecas-vaccine-amid-reports-of-rare-blood-clots/ 2021-03-21T20:43:45+00:00 https://old.international-biopharma.com/gilead-still-aiming-at-nash-broadens-an-alliance-with-novo/ 2021-03-21T20:42:34+00:00 https://old.international-biopharma.com/bluebirds-top-doctor-to-depart-as-company-grapples-with-safety-review/ 2021-03-21T20:41:17+00:00 https://old.international-biopharma.com/ftc-joins-overseas-antitrust-regulators-in-reexamination-of-pharma-ma/ 2021-03-21T20:40:17+00:00 https://old.international-biopharma.com/bluebird-says-gene-therapy-very-unlikely-cause-of-cancer-case-in-trial/ 2021-03-14T21:20:06+00:00 https://old.international-biopharma.com/vir-breaks-through-with-study-success-for-covid-19-antibody/ 2021-03-14T21:18:48+00:00 https://old.international-biopharma.com/detailed-lilly-data-give-mixed-picture-of-alzheimers-drugs-benefit/ 2021-03-14T21:16:12+00:00 https://old.international-biopharma.com/vaccine-factories-churn-out-millions-more-doses-speeding-us-rollout-of-coronavirus-shots/ 2021-03-14T21:12:57+00:00 https://old.international-biopharma.com/fda-sets-meeting-to-review-6-speedy-cancer-drug-approvals-as-evaluation-widens/ 2021-03-14T21:10:46+00:00 https://old.international-biopharma.com/spring-free-simplicity-for-higher-volumes-the-new-unisafe-safety-device-for-2-25ml-prefilled-syringes/ 2021-03-11T09:25:00+00:00 https://old.international-biopharma.com/wp-content/uploads/2021/03/Owen-Mumford-2.25-final-300x225-1.jpg https://old.international-biopharma.com/minicircle-dna-on-its-way-to-clinical-applications/ 2021-03-07T19:46:33+00:00 https://old.international-biopharma.com/biogen-to-spend-200m-on-gene-therapy-plant-in-north-carolina/ 2021-03-07T19:33:31+00:00 https://old.international-biopharma.com/biotechs-deal-refusals-led-to-pricey-buyout-by-merck/ 2021-03-07T19:31:08+00:00 https://old.international-biopharma.com/lilly-says-diabetes-shot-outperformed-rival-novo-drug-in-study/ 2021-03-07T19:30:04+00:00 https://old.international-biopharma.com/galapagos-reports-long-awaited-safety-data-for-inflammation-drug/ 2021-03-07T19:29:06+00:00 https://old.international-biopharma.com/vir-shares-tumble-after-apparent-setback-for-covid-19-drug/ 2021-03-07T19:28:15+00:00 https://old.international-biopharma.com/merck-to-buy-autoimmune-drugmaker-for-2b/ 2021-02-28T22:43:07+00:00 https://old.international-biopharma.com/fda-panel-backs-jjs-coronavirus-vaccine-clearing-way-for-shots-authorization/ 2021-02-28T22:41:40+00:00 https://old.international-biopharma.com/bluebird-reveals-new-details-on-cancer-cases-in-gene-therapy-trial/ 2021-02-28T22:39:49+00:00 https://old.international-biopharma.com/former-avexis-executives-launch-gene-therapy-startup-with-uncommon-targets/ 2021-02-28T22:38:13+00:00 https://old.international-biopharma.com/fda-authorizes-jjs-one-shot-coronavirus-vaccine/ 2021-02-28T22:35:12+00:00 https://old.international-biopharma.com/sarepta-wins-fda-approval-of-another-drug-for-rare-muscular-dystrophy/ 2021-02-28T22:32:46+00:00 https://old.international-biopharma.com/gates-foundation-backs-novartis-search-for-a-sickle-cell-cure/ 2021-02-21T22:41:39+00:00 https://old.international-biopharma.com/investment-firm-raises-300m-to-fund-medical-research-for-overlooked-diseases/ 2021-02-21T22:40:29+00:00 https://old.international-biopharma.com/pfizer-set-to-double-weekly-production-of-coronavirus-vaccine/ 2021-02-21T22:39:27+00:00 https://old.international-biopharma.com/10-biotechs-become-1-centessa-launches-with-250m-to-prove-unorthodox-rd-model/ 2021-02-21T22:38:27+00:00 https://old.international-biopharma.com/bluebird-stops-studies-of-sickle-cell-gene-therapy-after-new-cancer-cases/ 2021-02-21T22:37:29+00:00 https://old.international-biopharma.com/white-house-picks-brooks-lasure-to-head-medicare-medicaid-with-big-challenges-ahead/ 2021-02-21T22:36:31+00:00 https://old.international-biopharma.com/as-covid-19-becomes-a-business-vaccine-makers-confront-thorny-pricing-questions/ 2021-02-14T18:51:50+00:00 https://old.international-biopharma.com/lilly-cfo-steps-down-after-investigation-found-inappropriate-behavior/ 2021-02-14T18:50:48+00:00 https://old.international-biopharma.com/fda-advisers-recommend-agency-wait-on-keytruda-approval-in-tough-to-treat-breast-cancer/ 2021-02-14T18:47:44+00:00 https://old.international-biopharma.com/fda-clears-lillys-covid-19-antibody-cocktail-for-emergency-use/ 2021-02-14T18:46:28+00:00 https://old.international-biopharma.com/us-secures-200-million-more-vaccine-doses-from-pfizer-moderna/ 2021-02-14T18:45:06+00:00 https://old.international-biopharma.com/fda-approves-regeneron-drug-for-rare-genetic-form-of-high-cholesterol/ 2021-02-14T18:43:14+00:00 https://old.international-biopharma.com/neurocine-ends-partnership-with-voyager-for-parkinsons-gene-therapy/ 2021-02-07T21:36:24+00:00 https://old.international-biopharma.com/gsk-expands-curevac-vaccine-partnership-changing-course-after-setbacks/ 2021-02-07T21:35:05+00:00 https://old.international-biopharma.com/bristol-myers-finally-wins-fda-approval-for-cancer-cell-therapy/ 2021-02-07T21:22:48+00:00 https://old.international-biopharma.com/jj-asks-fda-for-emergency-clearance-of-coronavirus-vaccine/ 2021-02-07T21:21:07+00:00 https://old.international-biopharma.com/uk-to-start-study-testing-pfizer-astrazeneca-vaccines-together/ 2021-02-07T21:19:13+00:00 https://old.international-biopharma.com/jazz-pharma-to-buy-gw-pharma-maker-of-cbd-based-epilepsy-drug-for-7-2b/ 2021-02-07T21:17:19+00:00 https://old.international-biopharma.com/novartis-joins-sanofi-in-aiding-manufacture-of-coronavirus-vaccines/ 2021-01-31T22:49:48+00:00 https://old.international-biopharma.com/merck-stops-coronavirus-vaccine-development-in-surprise-setback/ 2021-01-31T22:48:21+00:00 https://old.international-biopharma.com/jj-says-single-dose-of-coronavirus-vaccine-66-effective-in-large-trial/ 2021-01-31T22:45:42+00:00 https://old.international-biopharma.com/sanofi-in-unusual-move-to-help-pfizer-biontech-make-coronavirus-vaccine-doses/ 2021-01-31T22:44:06+00:00 https://old.international-biopharma.com/with-latest-deal-merck-wades-into-cell-therapy-for-cancer/ 2021-01-31T22:42:44+00:00 https://old.international-biopharma.com/safety-finding-weighs-on-pfizers-inflammation-drug-and-could-spell-trouble-for-others/ 2021-01-31T22:40:31+00:00 https://old.international-biopharma.com/woodcock-steps-in-as-acting-fda-chief-with-crucial-vaccine-decisions-ahead/ 2021-01-22T10:11:34+00:00 https://old.international-biopharma.com/lillys-antibody-drug-prevents-covid-19-in-study-but-hurdles-to-use-remain/ 2021-01-22T10:06:39+00:00 https://old.international-biopharma.com/cancer-focused-biotech-turns-its-tools-to-building-a-2nd-generation-coronavirus-vaccine/ 2021-01-22T10:04:46+00:00 https://old.international-biopharma.com/beam-verve-stockpile-cash-as-investors-bank-on-gene-editing-progress/ 2021-01-22T10:03:07+00:00 https://old.international-biopharma.com/how-2-scientific-pioneers-teamed-up-to-run-askbio-bayers-new-gene-therapy-division/ 2021-01-22T10:01:06+00:00 https://old.international-biopharma.com/non-contact-clamp-on-flow-meters-bubble-detectors/ 2021-01-22T09:58:29+00:00 https://old.international-biopharma.com/us-to-pay-up-to-2-6b-for-more-doses-of-regenerons-covid-19-antibody-drug/ 2021-01-17T22:10:37+00:00 https://old.international-biopharma.com/jpm21-vaccines-soar-antibodies-struggle-as-covid-19-drugs-become-a-business/ 2021-01-17T22:08:48+00:00 https://old.international-biopharma.com/biomarin-tries-to-get-hemophilia-gene-therapy-back-on-track-with-positive-data/ 2021-01-17T22:02:04+00:00 https://old.international-biopharma.com/lilly-rockets-up-on-mixed-alzheimers-results/ 2021-01-17T21:59:45+00:00 https://old.international-biopharma.com/dana-farber-launches-venture-fund-targeting-incurable-cancers/ 2021-01-17T21:58:18+00:00 https://old.international-biopharma.com/us-pushes-for-wider-use-of-underutilized-covid-19-antibody-drugs-as-pandemic-worsens/ 2021-01-17T21:56:52+00:00 https://old.international-biopharma.com/cphi-worldwide-announces-new-november-2021-dates/ 2021-01-15T13:38:33+00:00 https://old.international-biopharma.com/mogrify-enters-research-collaboration-with-the-mrc-laboratory-of-molecular-biology/ 2021-01-11T09:13:41+00:00 https://old.international-biopharma.com/alnylam-with-positive-data-in-hand-prepares-to-submit-4th-drug-for-approval/ 2021-01-10T17:55:50+00:00 https://old.international-biopharma.com/bayer-partners-with-curevac-on-coronavirus-vaccine-development/ 2021-01-10T17:54:10+00:00 https://old.international-biopharma.com/a-new-well-connected-biotech-aims-to-fight-cancer-with-viruses/ 2021-01-10T17:50:27+00:00 https://old.international-biopharma.com/fda-says-changing-coronavirus-vaccine-dosing-could-put-public-health-at-risk/ 2021-01-10T17:46:46+00:00 https://old.international-biopharma.com/celgenes-cell-therapy-spinout-nets-292m-from-blank-check-merger/ 2021-01-10T17:38:10+00:00 https://old.international-biopharma.com/5-questions-facing-gene-therapy-in-2021/ 2021-01-10T17:30:23+00:00 https://old.international-biopharma.com/audentes-sees-fda-hold-lifted-after-3-trial-deaths-blighted-3b-program/ 2021-01-03T12:56:23+00:00 https://old.international-biopharma.com/chinas-sinopharm-sees-79-covid-19-vaccine-efficacy-picking-up-the-rear-behind-rivals/ 2021-01-03T12:54:21+00:00 https://old.international-biopharma.com/could-a-lymphoma-drug-work-better-against-covid-19-than-gileads-remdesivir/ 2021-01-03T12:52:23+00:00 https://old.international-biopharma.com/alkermes-sees-swift-turnaround-for-rejected-schizophrenia-med-as-fda-accepts-resubmission/ 2021-01-03T12:49:52+00:00 https://old.international-biopharma.com/enhancing-cancer-immunotherapy-by-restoring-a-warning-system/ 2021-01-03T12:47:41+00:00 https://old.international-biopharma.com/uk-authorizes-astrazeneca-oxford-coronavirus-vaccine-but-questions-linger/ 2021-01-03T12:44:48+00:00 https://old.international-biopharma.com/trump-administration-finalizes-policy-on-value-based-drug-deals/ 2020-12-26T21:50:49+00:00 https://old.international-biopharma.com/amgens-asthma-drug-takes-a-hit-making-for-stiffer-competition-with-regeneron/ 2020-12-26T21:47:51+00:00 https://old.international-biopharma.com/changing-identity-agios-to-sell-cancer-drug-business-to-servier/ 2020-12-26T21:45:37+00:00 https://old.international-biopharma.com/us-pays-another-2b-to-buy-more-doses-of-pfizer-biontech-coronavirus-vaccine/ 2020-12-26T21:43:15+00:00 https://old.international-biopharma.com/cancer-case-puts-uniqures-hemophilia-gene-therapy-on-hold-raising-alarms/ 2020-12-26T21:38:56+00:00 https://old.international-biopharma.com/with-biosimilars-looming-roche-makes-case-for-new-biologic-eye-drug/ 2020-12-26T21:33:14+00:00 https://old.international-biopharma.com/with-trial-plans-novo-wagers-its-diabetes-drug-can-help-treat-alzheimers/ 2020-12-18T10:48:49+00:00 https://old.international-biopharma.com/novartis-acquires-a-small-biotech-and-its-trio-of-brain-drugs/ 2020-12-18T10:45:01+00:00 https://old.international-biopharma.com/allogene-broadening-its-reach-helps-start-a-biotech-in-china/ 2020-12-18T10:43:26+00:00 https://old.international-biopharma.com/regeneron-pauses-studies-of-a-key-cancer-drug-citing-safety-concerns/ 2020-12-18T10:41:31+00:00 https://old.international-biopharma.com/lilly-pays-880m-for-prevail-pushing-further-into-genetic-medicine/ 2020-12-18T10:38:49+00:00 https://old.international-biopharma.com/macrogenics-wins-fda-approval-of-breast-cancer-drug/ 2020-12-18T10:36:56+00:00 https://old.international-biopharma.com/lilly-reports-strong-results-for-next-generation-diabetes-drug/ 2020-12-10T15:25:21+00:00 https://old.international-biopharma.com/bayer-strikes-a-deal-with-atara-wading-deeper-into-cell-therapy/ 2020-12-10T15:21:32+00:00 https://old.international-biopharma.com/jj-pushes-further-into-eye-gene-therapy/ 2020-12-10T15:11:05+00:00 https://old.international-biopharma.com/gilead-inks-a-billion-dollar-deal-for-a-hepatitis-drug/ 2020-12-10T15:08:17+00:00 https://old.international-biopharma.com/sarepta-shares-first-results-on-next-generation-duchenne-drug/ 2020-12-10T15:05:49+00:00 https://old.international-biopharma.com/amgen-readies-kras-blocking-cancer-drug-for-fda-filing/ 2020-12-10T15:02:58+00:00 https://old.international-biopharma.com/how-has-the-covid-19-pandemic-amplified-the-importance-of-the-ivd-industry/ 2020-12-10T14:18:40+00:00 https://old.international-biopharma.com/the-benefits-of-outsourcing-for-early-stage-drug-development/ 2020-12-10T14:15:49+00:00 https://old.international-biopharma.com/new-wave-of-rd-points-the-way-to-tackling-the-oldest-enemy/ 2020-12-10T14:12:21+00:00 https://old.international-biopharma.com/base-editing-the-story-so-far/ 2020-12-10T14:09:17+00:00 https://old.international-biopharma.com/re-modelling-drug-delivery-services-for-high-viscosity-formulations/ 2020-12-10T14:06:26+00:00 https://old.international-biopharma.com/a-global-approach-to-nitrosamine-impurity-testing-for-drug-products/ 2020-12-10T14:02:57+00:00 https://old.international-biopharma.com/transforming-the-healthcare-landscape-with-synthetic-biology-and-living-medicines/ 2020-12-10T13:59:37+00:00 https://old.international-biopharma.com/helping-labs-operate-at-peak-efficiency-to-foster-innovation/ 2020-12-10T13:56:51+00:00 https://old.international-biopharma.com/the-solution-to-improve-profitability-in-pharmaceutical-development-how-to-increase-pre-clinical-productivity-and-success-rates-in-clinical-trials/ 2020-12-10T13:53:59+00:00 https://old.international-biopharma.com/tightly-coupling-the-laboratory-to-the-pharmaceutical-manufacturing-process-is-essential-to-success/ 2020-12-10T13:49:44+00:00 https://old.international-biopharma.com/key-challenges-and-potential-solutions-for-optimising-downstream-bioprocessing-production-2/ 2020-12-10T13:46:27+00:00 https://old.international-biopharma.com/building-a-gene-therapy-challenges-and-changes-in-viral-vector-manufacture/ 2020-12-10T13:43:36+00:00 https://old.international-biopharma.com/compliance-capacity-a-checklist-to-assess-regulatory-readiness/ 2020-12-10T13:40:43+00:00 https://old.international-biopharma.com/hydrogel-encapsulation-the-new-paradigm-for-ambient-temperature-cell-shipping/ 2020-12-10T11:59:30+00:00 https://old.international-biopharma.com/driving-demand-for-parenteral-packaging-how-biologics-are-changing-the-face-of-pharma-packaging/ 2020-12-10T11:56:09+00:00 https://old.international-biopharma.com/ovids-plan-to-prove-a-shelved-sleeping-pill-for-a-rare-disease-ends-in-disappointment/ 2020-12-02T14:29:09+00:00 https://old.international-biopharma.com/with-anemia-data-agios-blood-disease-drug-takes-a-crucial-step-forward/ 2020-12-02T14:24:13+00:00 https://old.international-biopharma.com/regeneron-upenn-to-use-gene-therapy-tools-to-deliver-a-covid-19-antibody-drug/ 2020-12-02T14:21:48+00:00 https://old.international-biopharma.com/faa-says-first-flight-shipping-coronavirus-vaccine-takes-off/ 2020-12-02T14:17:58+00:00 https://old.international-biopharma.com/biogen-stocks-up-on-sages-brain-drugs-in-3b-deal/ 2020-12-02T14:13:06+00:00 https://old.international-biopharma.com/cdc-panel-recommends-giving-first-coronavirus-vaccines-to-healthcare-workers-nursing-home-residents/ 2020-12-02T14:10:03+00:00 https://old.international-biopharma.com/uniqures-gene-therapy-for-hemophilia-b-meets-first-goal-in-key-study/ 2020-11-25T14:51:09+00:00 https://old.international-biopharma.com/amgen-cuts-cytokinetics-loose-after-heart-drug-disappointment/ 2020-11-25T14:46:46+00:00 https://old.international-biopharma.com/pfizer-strikes-a-deal-with-newly-formed-china-biotech/ 2020-11-25T14:44:18+00:00 https://old.international-biopharma.com/who-recommends-against-gileads-veklury-in-break-with-us-guidelines/ 2020-11-25T14:42:07+00:00 https://old.international-biopharma.com/trump-administration-pushes-last-ditch-plans-to-lower-drug-prices/ 2020-11-25T14:40:20+00:00 https://old.international-biopharma.com/how-gilead-finally-spent-its-money/ 2020-11-25T14:36:10+00:00 https://old.international-biopharma.com/trial-success-for-2-coronavirus-vaccines-backs-up-early-research-bets/ 2020-11-19T15:12:26+00:00 https://old.international-biopharma.com/moderna-says-vaccine-prevents-covid-19-in-large-study-adding-to-hopes-for-several-protective-shots/ 2020-11-19T14:52:16+00:00 https://old.international-biopharma.com/copycat-to-top-selling-eye-drug-takes-a-step-toward-market/ 2020-11-19T14:49:33+00:00 https://old.international-biopharma.com/fda-unexpectedly-rejects-alkermes-schizophrenia-drug-citing-manufacturing-concerns/ 2020-11-19T14:43:11+00:00 https://old.international-biopharma.com/stem-cell-therapy-for-als-fails-a-large-clinical-trial/ 2020-11-19T14:40:57+00:00 https://old.international-biopharma.com/new-coronavirus-vaccine-data-bolster-pfizer-biontech-claims-of-strongly-effective-shot/ 2020-11-19T14:38:57+00:00 https://old.international-biopharma.com/intellia-beginning-treatment-in-crispr-study-secures-gates-foundation-backing/ 2020-11-16T09:45:25+00:00 https://old.international-biopharma.com/astrazeneca-cancer-drug-found-ineffective-for-covid-19/ 2020-11-16T09:44:09+00:00 https://old.international-biopharma.com/lilly-backs-a-biotechs-spinout-and-places-a-small-bet-on-protein-degradation/ 2020-11-16T09:39:14+00:00 https://old.international-biopharma.com/japanese-drugmaker-takes-full-control-of-a-roivant-biotech/ 2020-11-16T09:37:50+00:00 https://old.international-biopharma.com/pfizer-invests-in-homology-adding-to-gene-therapy-ambitions/ 2020-11-16T09:36:11+00:00 https://old.international-biopharma.com/new-webinar-digitalizing-cell-and-gene-therapies-manufacturing-a-lonza-case-study/ 2020-11-16T09:28:52+00:00 https://old.international-biopharma.com/allogene-shares-sink-on-early-look-at-an-off-the-shelf-car-t-for-myeloma/ 2020-11-06T10:58:58+00:00 https://old.international-biopharma.com/biogen-surges-as-fda-reviewers-appear-supportive-of-alzheimers-drug-approval/ 2020-11-06T10:55:20+00:00 https://old.international-biopharma.com/bluebird-faces-delay-for-sickle-cell-gene-therapy-as-rivals-inch-closer/ 2020-11-06T10:54:07+00:00 https://old.international-biopharma.com/merck-to-pay-almost-3b-for-velosbio-broadening-antibody-cancer-drug-push/ 2020-11-06T10:48:50+00:00 https://old.international-biopharma.com/gene-therapy-for-duchenne-muscular-dystrophy-nearing-final-tests/ 2020-11-06T10:46:23+00:00 https://old.international-biopharma.com/starting-material-for-mrna-vaccines-in-large-quantities/ 2020-11-06T10:07:19+00:00 https://old.international-biopharma.com/wp-content/uploads/2020/11/PF-IBI-visual-scaled-1.jpg https://old.international-biopharma.com/exact-sciences-challenging-illumina-to-buy-cancer-screening-company-thrive/ 2020-11-02T09:42:33+00:00 https://old.international-biopharma.com/bayer-to-buy-askbio-for-2b-in-bid-to-become-a-gene-therapy-player/ 2020-11-02T09:40:48+00:00 https://old.international-biopharma.com/novartis-molecular-partners-partner-to-develop-a-scalable-covid-19-drug/ 2020-11-02T09:39:10+00:00 https://old.international-biopharma.com/eqrx-builds-cancer-drug-pipeline-as-plans-to-challenge-big-pharma-take-shape/ 2020-11-02T09:34:45+00:00 https://old.international-biopharma.com/us-to-pay-lilly-375m-for-supply-of-covid-19-drug/ 2020-11-02T09:33:34+00:00 https://old.international-biopharma.com/bristol-myers-taps-machine-learning-biotech-for-help-finding-als-drugs/ 2020-11-02T09:30:17+00:00 https://old.international-biopharma.com/early-signs-of-survival-benefit-raise-optimism-around-a-small-biotechs-als-drug-2/ 2020-10-26T09:46:41+00:00 https://old.international-biopharma.com/crispr-therapeutics-reports-remissions-one-death-in-cancer-cell-therapy-study/ 2020-10-26T09:45:28+00:00 https://old.international-biopharma.com/ex-medivation-team-nets-500m-to-take-their-new-cancer-drugmaker-to-wall-street/ 2020-10-26T09:43:30+00:00 https://old.international-biopharma.com/sarepta-continuing-its-gene-therapy-push-helps-launch-a-startup/ 2020-10-26T09:41:45+00:00 https://old.international-biopharma.com/brief-gileads-veklury-becomes-first-fda-approved-drug-for-covid-19/ 2020-10-26T09:38:45+00:00